Home > Adrenergic Receptor & Adrenergic Receptor  & > Salbutamol Sulfate

Salbutamol Sulfate

硫酸沙丁胺醇,Albuterol

Salbutamol Sulfate是一种短效的β2-肾上腺素能受体激动剂，IC50为8.93 µM。

目录号
EY1042
EY1042
纯度
99.48%
99.48%
规格
100 mg
500 mg
原价
450
900
售价
450
900
库存
现货
现货
订购
订购
订购
订购
订购
订购
具体折扣请咨询客服

  • 生物活性

    Salbutamol Sulfate is a short-acting β2-adrenergic receptor agonist with an IC50 of 8.93 µM.

  • 体外研究

  • 体内研究

  • 激酶实验

  • 细胞实验

  • 动物实验

  • 不同实验动物依据体表面积的等效剂量转换表（数据来源于FDA指南）

    动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数


    例如，已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法：将88 mg/kg 乘以小鼠的Km系数（3），再除以大鼠的Km系数（6），得到该药物用于大鼠的等效剂量44 mg/kg。

  • 参考文献

    [1] Paetsch, P.R., et al. 1993. J Pharm Sci. 82: 22-24. PMID: 8381487
    [2] Kitamura, S., et al. 1977. Arzneimittelforschung. 27: 1959-1961. PMID: 21668
    [3] January, B., 1998. Br. J. Pharmacol. 123: 701-711. PMID: 9517390
    [4] Elena Rodriguez et. Al. Pulmonary Pharmacology & Therapeutics, 30, 22-31 (2015).

    分子式
    C13H21NO3.H2SO4    		 分子量
    337.39    		 CAS号
    51022-70-9    		 储存方式
    ﹣20 ℃冷藏长期储存。冰袋运输
    溶剂（常温）
    		 DMSO
    <1 mg/mL    		 Water
    70 mg/mL    		 Ethanol
    <1 mg/mL

    体内溶解度

  • Clinical Trial Information ( data from http://clinicaltrials.gov )

    NCT Number Conditions Interventions Sponsor/Collaborators Phases Start Date Last Updated
    NCT01903785 Bronchoconstriction|Inhaled Salbutamol|Cycling Performance Drug: Salbutamol|Drug: Placebo University of British Columbia|World Anti-Doping Agency (WADA) Phase 4 2013-05-01 2016-10-31
    NCT00585039 Asthma Drug: xopenex Phoenix Children's Hospital Phase 4 2005-09-01 2011-09-02
    NCT01844401 Asthma Drug: Albuterol Spiromax庐|Drug: ProAir HFA Teva Pharmaceutical Industries Phase 1 2013-04-01 2013-11-13
    NCT01323010 Asthma|Children Drug: Albuterol - Experimental|Drug: Albuterol - Control University of Sao Paulo|Fundao de Amparo Pesquisa do Estado de So Paulo 2011-09-01 2016-02-15
    NCT01203592 Congenital Myasthenic Syndrome Drug: Albuterol Mayo Clinic Phase 1 2010-09-01 2015-12-31
    NCT02447250 Bronchopulmonary Dysplasia|Very Low Birth Weight Drug: Varied albuterol dose response Oregon Health and Science University Phase 4 2013-10-01 2015-05-15
    NCT00124176 Asthma Drug: Racemic albuterol (R+S albuterol)|Drug: Levalbuterol (R albuterol) Children's Hospital of Philadelphia|Sunovion Phase 4 2004-04-01 2013-02-12
    NCT03059017 Drug Effect|Pulmonary Disease Drug: Salbutamol Sulphate|Drug: Niosomes British University In Egypt Phase 1 2017-02-05 2017-02-16
    NCT00577655 Asthma Drug: Albuterol|Drug: Placebo|Drug: Proventil HFA Teva Branded Pharmaceutical Products, R&D Inc.|Teva Pharmaceutical Industries Phase 3 2007-08-01 2016-09-02
    NCT01857323 Asthma|Chronic Obstructive Pulmonary Disease (COPD) Drug: Albuterol Spiromax Teva Pharmaceutical Industries Phase 3 2013-05-01 2015-05-19
    NCT02073747 Asthma Drug: Normal Saline|Drug: Albuterol University Medical Center of Southern Nevada 2015-04-01 2016-10-26
    NCT01791972 Exercise-Induced Bronchoconstriction (EIB) Drug: Albuterol Spiromax|Drug: Placebo Spiromax Teva Pharmaceutical Industries Phase 3 2013-03-01 2015-05-21
    NCT02966184 Status Asthmaticus Drug: preservative free albuterol University of Louisville Phase 4 2016-10-01 2016-11-14
    NCT01091337 Asthma Drug: Procaterol|Drug: Salbutamol Otsuka Pharmaceutical, Inc., Philippines Phase 4 2006-05-01 2010-03-22
    NCT02182713 Asthma Drug: Salbutamol sulfate/Ipratropium bromide|Drug: Salbutamol Boehringer Ingelheim Phase 4 1998-05-01 2014-07-07
    NCT00684866 Asthma Drug: Levalbuterol HFA MDI followed by Racemic albuterol HFA MDI|Drug: Racemic Albuterol followed by levalbuterol HFA MDI Sunovion Phase 2 2003-01-01 2012-02-21
    NCT03044938 Asthma|Heart Rate Fast Drug: salbutamol|Drug: Placebo Universidade Ibirapuera|University of Sao Paulo General Hospital Phase 4 2016-08-06 2017-02-02
    NCT00634829 Asthma|Bronchospasm Drug: albuterol (Armstrong Albuterol HFA)|Drug: Albuterol Sulfate (Provenetil-HFA)|Drug: Placebo-HFA Amphastar Pharmaceuticals, Inc. Phase 3 2008-02-01 2013-07-11
    NCT01218009 Asthma Drug: Placebo Spiromax|Drug: Albuterol Spiromax Teva Branded Pharmaceutical Products, R&D Inc.|Teva Pharmaceutical Industries Phase 3 2010-10-01 2015-05-01
    NCT00054964 Asthma Drug: Albuterol HFA-BOI|Drug: Albuterol HFA-MDI Teva Branded Pharmaceutical Products, R&D Inc.|Teva Pharmaceutical Industries Phase 2 2003-03-01 2017-02-03
    NCT00073840 Asthma Drug: levalbuterol Sunovion Phase 3 2002-12-01 2012-02-21

    注：以上所有数据均来自公开文献，并不保证对所有实验均有效，数据仅供参考。

  • 相关化合物库

  • 使用AMQUAR产品发表文献后请联系我们

相关推荐

X
  • 联系人 ：
  • 收件地址 ：
  • 电话号码 ：
  • 单位名称 ：
  • 产品货号 ：
  • 产品规格 ：
  • 发票抬头以及单位税号 ：